Familial dwarfism due to a novel mutation of the growth hormone- releasing hormone receptor gene

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 917-923

  Salvatori, Roberto ^a   Hayashida, César Y ^b   Aguiar Oliveira, Manuel H ^c   Phillips III, John A ^d   Souza, Anita H O ^c   Gondo, Rogério G ^b   Toledo, Sergio P A ^b   Conceicao, Maria M ^c   Prince, Melissa ^d   Maheshwari, Hiralal G ^e   Baumann, Gerhard ^e   Levine, Michael A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^d VANDERBILT UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; HORMONE RECEPTOR; HYDROCORTISONE; LUTEINIZING HORMONE; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; DNA DETERMINATION; DWARFISM; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; MALE; PEDIGREE; PRIORITY JOURNAL; RECEPTOR GENE; SHORT STATURE;

EID: 0033059058     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.917     Document Type: Article

References (48)

1. Lacey KA, Parkin JM. 1974 Causes of short stature: a community study of children in Newcastle Upon Tyne. Lancet.1: 42-45.
2. Rona RJ, Tanner JM. 1977 Aetiology of idiopathic growth hormone deficiency in England and Wales. Arch Dis Chid. 52:197-208.
3. Vimpani GV, Vimpani AF, Lidgard GP, Cameron EH, Farquhar JW. 1977 Prevalence of severe growth hormone deficiency. Br Med J. 2:427-430.
4. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. 1994 Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency. J Pediatr. 125:29-35.
5. Cacciari E, Zucchini S, Carla G, et al. 1990 Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance. Arch Dis Child. 65:1199-1202.
6. Rimoin DL, Phillips III JA. 1997 Genetic disorders of the pituitary gland. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Principle and Practice of Medical Genetics, 3rd ed. New York: Churchill Livingstone; 1331-1364.
7. Wagner JK, Eble A, Hindmarsh PC, Mullis PE. 1998 Prevalence of human GH-1 alterations in patients with isolated growth hormone deficiency. Pediatr Res. 43:105-110.
8. Hartman ML, Veldhius JD, Thorner MO. 1993 Normal control of growth hormone secretion. Horm Res. 40:37-47.
9. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB. 1982 Growth hormone-releasing factor from human pancreatic tumor that causes acromegaly. Science. 218:585-587.
10. Asa SL, Kovacs K, Stefaneu L, et al. 1990 Pituitary somatomammotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone. Proc Soc Exp Biol Med. 193:232-235.
11. Vallar L, Spada A, Giannatasio G. 1987 Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
12. Burton FH, Hasel KW, Bloom FE, Sutcliffe JG. 1991 Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature. 350:74-77.
13. Struthers RS, Vale WW, Arias C, Sawchenco PE, Montminy MR. 1991 Somatotroph hypoplasia and dwarfism in in transgenic mice expressing a non-phosphorylable CREB mutant. Nature. 350:622-624.
14. Perez Jurado LA, Phillips III JA, Francke U. 1994 Exclusion of growth hormone-releasing hormone gene mutations in familial isolated growth hormone deficiency by linkage and single strand conformation analysis. J Clin Endocrinol Metabol. 78:622-628.
15. Jansson J-O, Downs TR, Beamer WG, Frohman LA. 1986 Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice. Science. 232:511-512.
16. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE. 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet. 4:227-232.
17. Lin S-C, Lin CR, Gukovsky I, Lusis AJ, Sawchenco PE, Rosenfeld MG. 1993 Molecular basis of the little mouse phenotype and implications for cell-type specific growth. Nature. 364:209-214.
18. Wajnrajch MP, Gertner JM, Harbison MD, Chua Jr SC, Leibel RL. 1996 Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet. 12:88-90.
19. Baumannn G, Maheshwari H. 1997 Severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr Suppl. 423:33-38.
20. Netchine I, Talon P, Dastot F, Vitaux F, Goossens M, Amselem S. 1998 Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. J Clin Endocrinol Metab. 83:432-436.
21. Gaylinn BD, Harrison JK, Zysk JR, Lyons CE, Lynch KR, Thorner MO. 1993 Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol. 7:77-84.
22. Greulich WW, Pyle SI. 1959 A radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Stanford: Stanford University Press.
23. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
24. Miller SA, Dykes DD, Polesky HF. 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16:1215.
25. Maheshwari HG, Baumann G. 1997 Genomic organization and structure of the human growth hormone releasing hormone receptor gene. Proc 79th Annual Meeting of The Endocrine Society, Minneapolis, MN 1997 p.156.
26. Petersenn S, Rasch AC, Heyens M, Schulte HM. 1998 Structure and regulation of the human growth hormone-releasing hormone receptor gene. Mol Endocrinol. 12:233-247.
27. Sheffield VC, Cox DR, Lerman LS, Myers RM. 1989 Attachment of a 40 base pair G+C reach sequence (G-C clamp) to genomic DNA fragment by the polymerase chain reaction results in improved detection of single base changes. Proc Natl Acad Sci USA. 86:232-236.
28. Miric A, Levine MA. 1992 Analysis of the preproPTH gene by denaturing gradient gel electrophoresis in familial isolated hypoparathyroidism. J Clin Endocrinol Metab. 74:509-516.
29. Cox DR, O'Connor K, Hebert S, et al. 1994 Construction and analysis of panel of "whole genome" radiation hybrids. Am J Hum Genet. 55:A23.
30. Boehnke M, Lange K, Cox DR. 1991 Statistical methods for multipoint radiation hybrid mapping. Am J Hum Genet. 49:1174-88.
31. Li S, Crenshaw III EB, Rawson EJ, Simmonds DM, Swanson LV, Rosenfeld MG. 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 347:528-533.
32. Sornson MW, Wu W, Dasen JS. 1996 Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defectìve in Ames dwarfism. Nature. 384:327-333.
33. Takeuchi T, Suzuki H, Sakurai S, Nogami H, Okuma S, Ishikawa H. 1990 Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by polymerase chain reaction. Endocrinology. 126:31-38.
34. Wu W, Cogan JD, Pfaffle RW, et al. 1998 Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 18:147-149.
35. Cao Y, Wagner JK, Hindmarsh PC, Eble A, Mullis PE. 1995 Isolated growth hormone deficiency: testing the little mouse hypothesis in man and exclusion of mutations within the extracellular domain of the growth hormone-releasing hormone receptor. Pediatr Res. 38:962-966.
36. Horowitz DS, Krainer AR. 1994 Mechanism for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet. 10:100-105.
37. Marcus S, Christiensen E, Malm G. 1993 Molecular analysis of the mutation in five unrelated patients with Lesch Nyhan syndrome. Hum Mutat. 2:473-477.
38. Kumar A, Kandt RS, Wolpert C, Roses AD, Pericak-Vance MA, Gilbert JR. 1997 A novel splice site mutation (156 + 1G→A) in the TSC2 gene. Hum Mutat. 9:64-65.
39. Kwan S-P, Hagemann TL, Blaese RM, Knutsen A, Rosen FS. 1995 Scanning of the Wiscott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. Hum Mol Genet. 4:1995-1998.
40. Uchino T, Snyderman SE, Lambert M et al. 1995 Molecular basis of phenotypic variation in patients with argininemia. Hum Genet. 96:255-260.
41. Tassabehji M, Newton VE, Read AP. 1994 Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet. 8:251-255.
42. Puck JM, Middleton L, Pepper AE. 1997 Carrier and prenatal diagnosis of X-linked severe combined immunodeficiency: Mutation detection methods and utilization. Hum Genet. 99:628-633.
43. Fuchs S, van de Pol D, Beudt U, et al. 1996 Three novel and two recurrent mutations of the Norrie disease gene in patients with Norrie syndrome. Hum Mutat. 8:85-88.
44. Ley TJ, Anagnou NP, Pepe G, Nienhius AW. 1982 RNA processing errors in patients with β-thalassemia. Proc Natl Acad Sci USA. 79:4775-4779.
45. Lossi A-M, Berge-Lefranc J-L. 1989 The mRNA transcripts from a mutant β-globin gene derived from splicing at preferential cryptic sites. FEBS Lett. 256:163-166.
46. Niimura H, Bachinski LL, Sangwatanaroj S, et al. 1998 Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 338:1248-1257.
47. Cooper DN, Youssoufian H. 1988 The CpG dinucleotide and human genetic disease. Hum Genet. 78:151-5.
48. Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. 1995 Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 56:368-373.